Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
pimavanserin 5-ht 2a receptor NA Successful target TTD , DGIDB Hallucinations[MeSHID:D006212]
Delusions[MeSHID:D003702]
Psychotic Disorders[MeSHID:D011618]
Parkinson Disease[MeSHID:D010300]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 1.74 approved unknown
pimavanserin 5-ht 2a receptor NA Successful target TTD , DGIDB Hallucinations[MeSHID:D006212]
Delusions[MeSHID:D003702]
Psychotic Disorders[MeSHID:D011618]
Parkinson Disease[MeSHID:D010300]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 1.74 approved antagonist
pimavanserin 5-hydroxytryptamine receptor 2a small molecule NA drugbank , DGIDB Hallucinations[MeSHID:D006212]
Delusions[MeSHID:D003702]
Psychotic Disorders[MeSHID:D011618]
Parkinson Disease[MeSHID:D010300]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 1.74 approved,investigational inverse agonist
pimavanserin 5-hydroxytryptamine receptor 2a small molecule NA drugbank , DGIDB Hallucinations[MeSHID:D006212]
Delusions[MeSHID:D003702]
Psychotic Disorders[MeSHID:D011618]
Parkinson Disease[MeSHID:D010300]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 1.74 approved,investigational inverse agonist,antagonist
pimavanserin 5-hydroxytryptamine receptor 2c small molecule NA drugbank Hallucinations[MeSHID:D006212]
Delusions[MeSHID:D003702]
Psychotic Disorders[MeSHID:D011618]
Parkinson Disease[MeSHID:D010300]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved,investigational inverse agonist
pimavanserin sigma non-opioid intracellular receptor 1 small molecule NA drugbank Hallucinations[MeSHID:D006212]
Delusions[MeSHID:D003702]
Psychotic Disorders[MeSHID:D011618]
Parkinson Disease[MeSHID:D010300]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved,investigational binder
click here to return to the previous page